8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer)
Published . Updated .
Key takeaways
- 8-K - TEVA PHARMACEUTICAL INDUSTRIES filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: TEVA
- Market reaction: TEVA +5.8% on the day (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - TEVA PHARMACEUTICAL INDUSTRIES filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- TEVA Teva Pharmaceutical Industries
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+20.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+9.0% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.3% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TEVA | -0.66% | +1.97% | base | +5.78% | after close | after close | after close |
| XLV | -2.95% | -0.31% | base | +0.17% | after close | after close | after close |
| XBI | +1.84% | +3.78% | base | +2.44% | after close | after close | after close |
| LLY | -9.22% | -2.71% | base | +0.62% | after close | after close | after close |
| JNJ | -0.68% | +1.70% | base | -0.28% | after close | after close | after close |
| PFE | -3.00% | -2.47% | base | -0.75% | after close | after close | after close |
| MRK | -4.45% | -1.43% | base | -1.90% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001171843-26-007054 Size: 633 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries (TEVA) the next day, across 12 earlier stories: average +1.09%, largest gain +2.65%, largest drop -1.93%, from 12 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | the next day | +1.09% | +2.65% | -1.93% | 12 |
| Teva Pharmaceutical Industries (TEVA) | three days later | +1.59% | +5.28% | +0.67% | 5 |
- Most Israelis think settlements policy should change to avoid more sanctions, poll finds
- Israel launches online portal for counterterrorism sanctions
- Mapping sanctions against Israel: 121 measures across 61 countries - The Jewish People Policy Institute
- British MP calls for sanctions on Israeli state, not just settlers
- Exclusive: Miliband set on sanctions regardless of Israel election outcome as officials try to weaken measures
- Pro-Palestine MPs call for more sanctions against Israel over ‘Gaza aid restrictions’ | Framing Analysis
Price since this story was published: Teva Pharmaceutical Industries (TEVA)
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | that day | -0.28% | still updating |
| JNJ | three days earlier | +1.70% | final price |
| JNJ | five days earlier | -0.68% | final price |
| LLY | that day | +0.62% | still updating |
| LLY | three days earlier | -2.71% | final price |
| LLY | five days earlier | -9.22% | final price |
| MRK | that day | -1.90% | still updating |
| MRK | three days earlier | -1.43% | final price |
| MRK | five days earlier | -4.45% | final price |
| PFE | that day | -0.75% | still updating |
| PFE | three days earlier | -2.47% | final price |
| PFE | five days earlier | -3.00% | final price |
| Teva Pharmaceutical Industries (TEVA) | that day | +5.78% | still updating |
| Teva Pharmaceutical Industries (TEVA) | three days earlier | +1.97% | final price |
| Teva Pharmaceutical Industries (TEVA) | five days earlier | -0.66% | final price |
| XBI | that day | +2.44% | still updating |
| XBI | three days earlier | +3.78% | final price |
| XBI | five days earlier | +1.84% | final price |
| XLV | that day | +0.17% | still updating |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 56 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 74 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Teva Pharmaceutical Industries (TEVA)
Companies carried with this story
- TEVA Teva Pharmaceutical Industries
Teva Pharmaceutical Industries (TEVA) is linked, with no stored direction, high confidence in the 3 Nov 2026 story “8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> TEVA
Teva Pharmaceutical Industries (TEVA)
On 3 Nov 2026, “8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer)” is the story that connects Teva Pharmaceutical Industries (TEVA) to this story.
The link for Teva Pharmaceutical Industries (TEVA) is this: SEC 8-K filing -> direct issuer disclosure -> TEVA
Dates in the story, and the Teva Pharmaceutical Industries (TEVA) price range
TEVA traded between 40.05 and 42.56 across 3 sessions. The latest close on file is 40.68.
A simple score for Teva Pharmaceutical Industries (TEVA)
14 out of 100Price not final
“8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.